McIlrath & Eck’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $467 | Hold |
20
| – | – | ﹤0.01% | 901 |
|
|
2025
Q1 | $309 | Hold |
20
| – | – | ﹤0.01% | 900 |
|
|
2024
Q4 | $375 | Hold |
20
| – | – | ﹤0.01% | 944 |
|
|
2024
Q3 | $227 | Hold |
20
| – | – | ﹤0.01% | 953 |
|
|
2024
Q2 | $190 | Hold |
20
| – | – | ﹤0.01% | 925 |
|
|
2024
Q1 | $670 | Hold |
20
| – | – | ﹤0.01% | 883 |
|
|
2023
Q4 | $547 | Hold |
20
| – | – | ﹤0.01% | 876 |
|
|
2023
Q3 | $1.24K | Hold |
20
| – | – | ﹤0.01% | 801 |
|
|
2023
Q2 | $2.08K | Hold |
20
| – | – | ﹤0.01% | 782 |
|
|
2023
Q1 | $3.61K | Hold |
20
| – | – | ﹤0.01% | 715 |
|
|
2022
Q4 | $7.91K | Hold |
20
| – | – | ﹤0.01% | 572 |
|
|
2022
Q3 | $7K | Hold |
20
| – | – | ﹤0.01% | 597 |
|
|
2022
Q2 | $7K | Hold |
20
| – | – | ﹤0.01% | 576 |
|
|
2022
Q1 | $9K | Sell |
20
-6
| -23% | -$2.7K | ﹤0.01% | 550 |
|
|
2021
Q4 | $12K | Hold |
26
| – | – | ﹤0.01% | 515 |
|
|
2021
Q3 | $15K | Hold |
26
| – | – | ﹤0.01% | 462 |
|
|
2021
Q2 | $14K | Buy |
26
+6
| +30% | +$3.23K | ﹤0.01% | 470 |
|
|
2021
Q1 | $16K | Buy |
+20
| New | +$16K | 0.01% | 388 |
|